Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016.
Mer å spørre om
How much does the CEO of GSK earn?
What is Emma Walmsley's leadership style?
Who is the new CEO of GSK?
Who is the CEO of Emma?
Emma Walmsley
Daglig leder i GSK
Dame Emma Natasha Walmsley DBE er administrerende direktør i GlaxoSmithKline. Hun etterfulgte Sir Andrew Witty, som gikk av med pensjon i mars 2017. Før GSK jobbet hun for L'Oréal i 17 år, og var ikke-utøvende direktør i Diageo frem til september... Wikipedia (engelsk)
Født: juni 1969 (alder 55 år), Barrow-in-Furness, Storbritannia
Ektefelle: David Owen (g. 1995)
Foreldre: Robert Walmsley og Christina V Melvill
Emma has been GSK CEO and Board Director since April 2017. She has been a member of the GSK Leadership Team since 2011.
Proud to be leading GSK as we unite science, technology and talent to get ahead of… · Experience: GSK · Education: University of Oxford · Location: London ...